Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas. [electronic resource]
Producer: 19910917Description: 207-13 p. digitalISSN:- 1053-8550
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Drug Administration Schedule
- Drug Evaluation
- Female
- Fluorouracil -- administration & dosage
- Head and Neck Neoplasms -- drug therapy
- Humans
- Interleukin-2 -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.